August 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
August 2026
The global AI in cancer immunotherapy drugs market size was evaluated at USD 2.80 billion in 2025 and is predicted to hit around USD 27.79 billion by 2035, growing at a CAGR of 25.80%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
September 2026
The CAR-T therapies for blood cancers market generated USD 6.80 billion in 2025, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
August 2026
The ovarian cancer drugs market reached USD 4.09 billion in 2025, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
August 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
August 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
August 2026
The global cancer registry software market size is expected to increase from USD 94.68 million in 2025 to hit around USD 301.40 million by 2035, with a CAGR of 12.28%.
August 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
August 2026
The global breast cancer market size was estimated at USD 26.23 billion in 2025 and is projected to hit around USD 40.11 billion by 2035 with a CAGR of 4.34%.
August 2026
The cancer biopsy market size is estimated at USD 36.55 billion in 2025 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
July 2026
The global cancer diagnostics market size was exhibited at USD 170 billion in 2025 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 11.65 billion in 2025, with a CAGR of 6.83%.
July 2026
The global next-generation cancer therapeutics market size was evaluated at USD 92.54 billion in 2025 and is predicted to hit around USD 186.65 billion by 2035, growing at a CAGR of 7.27%.
July 2026
The global genomics in cancer care market size was evaluated at USD 24.39 billion in 2025 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
June 2026
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,611.83 million 2035 increasing from USD 823.30 million in 2025, with a CAGR of 18.80%.
June 2026
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 2,023.79 million by 2035, growing at a CAGR of 15.58%.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global skin cancer diagnostic market size is evaluated at USD 8.97 billion in 2025 and is predicted to hit around USD 14.60 billion by 2035, with a CAGR of 4.99%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.38 billion in 2025, with a CAGR of 5.17%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com